Prudential Financial’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Sell |
64,170
-31,260
| -33% | -$1.36M | ﹤0.01% | 1220 |
|
|
2025
Q1 | $2.61M | Sell |
95,430
-1,387
| -1% | -$38K | ﹤0.01% | 1168 |
|
|
2024
Q4 | $3.89M | Sell |
96,817
-25,273
| -21% | -$1.02M | 0.01% | 970 |
|
|
2024
Q3 | $5.78M | Buy |
122,090
+72,370
| +146% | +$3.43M | 0.01% | 932 |
|
|
2024
Q2 | $1.48M | Buy |
49,720
+325
| +0.7% | +$9.7K | ﹤0.01% | 1596 |
|
|
2024
Q1 | $1.99M | Buy |
+49,395
| New | +$1.99M | ﹤0.01% | 1452 |
|
|
2022
Q1 | – | Sell |
-29,695
| Closed | -$1.92M | – | 2655 |
|
|
2021
Q4 | $1.92M | Buy |
29,695
+7,905
| +36% | +$510K | ﹤0.01% | 1564 |
|
|
2021
Q3 | $1.28M | Buy |
21,790
+7,400
| +51% | +$435K | ﹤0.01% | 1681 |
|
|
2021
Q2 | $698K | Buy |
14,390
+1,570
| +12% | +$76.2K | ﹤0.01% | 2002 |
|
|
2021
Q1 | $498K | Buy |
+12,820
| New | +$498K | ﹤0.01% | 2134 |
|